Isomorphic Labs
About Isomorphic Labs
Isomorphic Labs develops technology to accelerate the drug discovery process for the pharmaceutical and biotechnology industries. As a subsidiary of Alphabet Inc., the company focuses on unlocking scientific insights to identify new medicines and treatments. Recent coverage has focused on the company's role within the broader landscape of technology investment and venture capital funding in the United Kingdom.
FF News has published 2 stories featuring Isomorphic Labs, most recently "UK Venture Capital Hits Four-Year High as AI Boom Drives £14.2 Billion Investment" (25 August 2026).
Part of: Alphabet Inc.